Page 172 - HHR-HNR 2.0

Tuinman, M. A., S. M. Gazendam-Donofrio and J. E. Hoekstra-Weebers (2008). \u0022Screening and referral for psychosocial distress in oncologic practice: use of the Distress Thermometer.\u0022 Cancer 113(4): 870-878.\u000DVan As, C. J., B. M. Op de Coul, F. J. Van den Hoogen, F. J. Koopmans-van Beinum and F. J. Hilgers (2001). \u0022Quantitative videofluoroscopy: a new evaluation tool for tracheoesophageal voice production.\u0022 Arch Otolaryngol Head Neck Surg 127(2): 161-169.\u000DVan As, C. J., M. Tigges, T. Wittenberg, B. M. Op de Coul, U. Eysholdt and F. J. Hilgers (1999). \u0022High-speed digital imaging of neoglottic vibration after total laryngectomy.\u0022 Arch Otolaryngol Head Neck Surg 125(8): 891-897.\u000DVan Dam, F. S., F. J. Hilgers, G. Emsbroek, F. I. Touw, C. J. Van As and J. N. de (1999). \u0022Deterioration of olfaction and gustation as a consequence of total laryngectomy.\u0022 Laryngoscope 109(7 Pt 1): 1150-1155.\u000DVan den Berg, M. G. A. (2014). From recognition of malnutrition to improvement of dietery counseling for patients with head and neck cancer, Radboud University Nijmegen.\u000DVan den Broek, G. B., A. J. Balm, M. W. Van den Brekel, M. Hauptmann, J. H. Schornagel and C. R. Rasch (2006). \u0022Relationship between clinical factors and the incidence of toxicity after intra-arterial chemoradiation for head and neck cancer.\u0022 Radiother Oncol 81(2): 143-150.\u000DVan der Molen, L., W. D. Heemsbergen, R. De Jong, M. A. Van Rossum, L. E. Smeele, C. R. Rasch and F. J. Hilgers (2013). \u0022Dysphagia and trismus after concomitant chemo-Intensity-Modulated Radiation Therapy (chemo-IMRT) in advanced head and neck cancer; dose-effect relationships for swallowing and mastication structures.\u0022 Radiother Oncol 106(3): 364-369.\u000DVan der Molen, L., A. F. Kornman, M. N. Latenstein, M. W. Van den Brekel and F. J. Hilgers (2013). \u0022Practice of laryngectomy rehabilitation interventions: a perspective from Europe/the Netherlands.\u0022 Curr Opin Otolaryngol Head Neck Surg 21(3): 230-238.\u000DVan der Molen, L., M. A. Van Rossum, A. H. Ackerstaff, L. E. Smeele, C. R. Rasch and F. J. Hilgers (2009). \u0022Pretreatment organ function in patients with advanced head and neck cancer: clinical outcome measures and patients\u0027 views.\u0022 BMC Ear Nose Throat Disord 9: 10.\u000Dvan der Molen, L., M. A. van Rossum, L. M. Burkhead, L. E. Smeele and F. J. Hilgers (2009). \u0022Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review.\u0022 Eur Arch Otorhinolaryngol 266(6): 889-900.\u000Dvan der Molen, L., M. A. van Rossum, L. M. Burkhead, L. E. Smeele, C. R. Rasch and F. J. Hilgers (2011). \u0022A randomized preventive rehabilitation trial in advanced head and neck cancer patients treated with chemoradiotherapy: feasibility, compliance, and short-term effects.\u0022 Dysphagia 26(2): 155-170.\u000DVan der Molen, L., M. A. Van Rossum, I. Jacobi, R. J. Van Son, L. E. Smeele, C. R. Rasch and F. J. Hilgers (2012). \u0022Pre- and posttreatment voice and speech outcomes in patients with advanced head and neck cancer treated with chemoradiotherapy: expert listeners\u0027 and patient\u0027s perception.\u0022 J Voice 26(5): 664 e625-633.\u000DVan der Molen, L., M. A. Van Rossum, C. R. Rasch, L. E. Smeele and F. J. Hilgers (2014). \u0022Two-year results of a prospective preventive swallowing rehabilitation trial in patients treated with chemoradiation for advanced head and neck cancer.\u0022 Eur Arch Otorhinolaryngol 271(5): 1257-1270.\u000DVan der Torn, M., I. M. Verdonck-de Leeuw, D. J. Kuik and H. F. Mahieu (2002). \u0022Communicative suitability of voice following radiotherapy for T1 glottic carcinoma: testing the reliability of a rating instrument.\u0022 J Voice 16(3): 398-407.\u000DVan Gogh, C. D., H. F. Mahieu, D. J. Kuik, R. N. Rinkel, J. A. Langendijk and I. M. Verdonck-de Leeuw (2007). \u0022Voice in early glottic cancer compared to benign voice pathology.\u0022 Eur Arch Otorhinolaryngol 264(9): 1033-1038.\u000D171\u000D